Patent · US Active

Pyrimidine compounds

US7737157B2 · kind B2 · utility

0Cited by

3References

15Claims

0Family size

Assignee

Hutchison MediPharma Enterprises Limited · BS

Inventors

Wei-Guo Su · Shanghai, CN
Hong Jia · Beijing, CN
Rick B. Ye · Shanghai, CN
Yang Sai · Shanghai, CN

Key dates

Filing date	Aug 29, 2008
Grant date	Jun 15, 2010
Priority date	—
Expiry date	Aug 29, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Pyrimidine compounds of the following formula:wherein R1, R2, R3, R4, R5, X, Q1, Q2, and Q3 are defined herein. Also disclosed is a method of treating cancer with one of these compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.